Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Membrane pores in the pathogenesis of neurodegenerative disease.

Kagan BL.

Prog Mol Biol Transl Sci. 2012;107:295-325. doi: 10.1016/B978-0-12-385883-2.00001-1. Review.

PMID:
22482454
2.

Amyloid peptide pores and the beta sheet conformation.

Kagan BL, Thundimadathil J.

Adv Exp Med Biol. 2010;677:150-67. Review.

PMID:
20687488
3.

Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis.

Kourie JI, Culverson AL, Farrelly PV, Henry CL, Laohachai KN.

Cell Biochem Biophys. 2002;36(2-3):191-207. Review.

PMID:
12139405
4.

Amyloid peptide channels.

Kagan BL, Azimov R, Azimova R.

J Membr Biol. 2004 Nov;202(1):1-10. Review.

PMID:
15702375
5.

The expanding realm of prion phenomena in neurodegenerative disease.

Frost B, Diamond MI.

Prion. 2009 Apr-Jun;3(2):74-7. Epub 2009 Apr 16. Review.

6.

Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.

Meredith SC.

Ann N Y Acad Sci. 2005 Dec;1066:181-221. Review.

PMID:
16533927
7.

Glycosaminoglycans, protein aggregation and neurodegeneration.

Papy-Garcia D, Christophe M, Huynh MB, Fernando S, Ludmilla S, Sepulveda-Diaz JE, Raisman-Vozari R.

Curr Protein Pept Sci. 2011 May;12(3):258-68. Review.

PMID:
21348835
8.

Interactions of amyloidogenic proteins.

Giasson BI, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2003;4(1-2):49-58. Review.

PMID:
14528052
9.

Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.

Hong L, Simon JD.

Metallomics. 2011 Mar;3(3):262-6. doi: 10.1039/c0mt00052c. Epub 2010 Nov 29. Review.

PMID:
21116546
10.

Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.

Gadad BS, Britton GB, Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182. Review.

PMID:
21460436
11.

Nucleic acid induced protein aggregation and its role in biology and pathology.

Yin J, Chen R, Liu C.

Front Biosci (Landmark Ed). 2009 Jun 1;14:5084-106. Review.

PMID:
19482606
12.

Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.

El-Agnaf OM, Irvine GB.

J Struct Biol. 2000 Jun;130(2-3):300-9. Review.

PMID:
10940234
13.

Structure and function of the molecular chaperone Hsp104 from yeast.

Grimminger-Marquardt V, Lashuel HA.

Biopolymers. 2010 Mar;93(3):252-76. doi: 10.1002/bip.21301. Review.

PMID:
19768774
14.

[Conformationally altered proteins cause neurodegenerative diseases].

Ingelsson M, Nilsson L, Basun H, Aquilonius SM, Lannfelt L.

Lakartidningen. 2005 Nov 21-27;102(47):3542-3, 3545-6, 3549 passim. Review. Swedish.

PMID:
16408392
16.

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Glabe CG.

Neurobiol Aging. 2006 Apr;27(4):570-5. Epub 2006 Feb 14. Review.

PMID:
16481071
17.

Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

Lashuel HA, Lansbury PT Jr.

Q Rev Biophys. 2006 May;39(2):167-201. Epub 2006 Sep 18. Review.

PMID:
16978447
18.

[Neurodegenerative conformational disease and its molecular bases].

Li WW, Cai DF, Ren HM.

Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Review. Chinese.

PMID:
16850610
19.

Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

Windisch M, Wolf HJ, Hutter-Paier B, Hofmeister A, Wronski R.

Curr Alzheimer Res. 2007 Sep;4(4):446-57. Review.

PMID:
17908049
20.

Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus.

Menestrina G, Dalla Serra M, Comai M, Coraiola M, Viero G, Werner S, Colin DA, Monteil H, Prévost G.

FEBS Lett. 2003 Sep 18;552(1):54-60. Review.

Supplemental Content

Support Center